Zonisamide
- Level
- Commodity
- Parent
- 51141500
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51141514This classification denotes an anticonvulsant agent with the molecular formula C8H8N2O3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 459384H98V, chemically known as 1,2-benzisoxazole-3-methanesulfonamide but generally known as zonisamide, which bears US NIH Compound Identifier 5734. European Medicines Agency schedules Zonisamide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00187MIG. The term ZONISAMIDE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 39, No. 5, 1985, List 25). World Health Organization schedules zonisamide in its Anatomical Therapeutic Chemical (ATC) Classification. ZONISAMIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule zonisamide under HS 29350090 and SITC 51580. As of Q4 2014, ZONISAMIDE remains the US FDA Preferred Term for this commodity. Zonisamide bears US NLM identifiers UMLS ID C0078844 and NCI Concept Code C47790. SMILES: S(=O)(=O)(N)CC1NOC2C1CCCC2.
Same parent
Under 51141500 · 80Activities that produce or sell this
KBLI · 8Inherited from family 51140000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.